Patents by Inventor Rolandas Meskys

Rolandas Meskys has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11584772
    Abstract: Disclosed are W-position modified cytidine nucleotides of formula (I). Provided herein are methods of chemical synthesis of AP-modified cytidine nucleoside triphosphates and their applications as well as uses of the cytidine analogues for the synthesis of modified nucleic acids. The nucleic acid molecule includes DNA, RNA or a combination of DNA/RNA. One of many applications of modified cytidine nucleotides described herein is enzyme selection, when an enzyme of interest bears an activity of an esterase, amidase, oxidoreductase, lyase, ligase or other enzymatic activity, formula (I) wherein the substituants are as defined in the appended claims.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: February 21, 2023
    Assignee: VILNIUS UNIVERSITY
    Inventors: Rolandas Meskys, Jevgenija Jakubovska, Daiva Tauraite
  • Publication number: 20220367007
    Abstract: The invention generally relates to the field of protein sequences and of generation of functional protein sequences. More particularly, the invention concerns a method for generating functional protein sequences with generative adversarial networks. The described method for functional sequence generation comprises plurality of steps, each of which is crucial to ensure the high percentage of functional sequences in the final sequence set: selecting a plurality of existing protein sequences to define the approximate sequence space for the later generated synthetic sequences, processing the selected protein sequences, approximating the unknown true distribution of amino acids of the pre-processed sequences using a variation of generative adversarial networks, obtaining protein sequences from the approximated distribution, processing of the obtained protein sequences. The described method provides a resource (e.g.
    Type: Application
    Filed: September 10, 2019
    Publication date: November 17, 2022
    Inventors: Laurynas Karpus, Vykintas Jauniskis, Donatas Repecka, Rolandas Meskys
  • Publication number: 20210355486
    Abstract: The present invention relates to catalytic biomolecule characterization and microfluidics. It is used for identification of nucleic acids encoding active catalytic molecules in the plurality of nucleic acids and for gathering information about catalytic biomolecule activity. It can also be used for exploring different properties of regulating sequences that modulate expression of catalytic biomolecules by recording that information into the DNA sequence of the same catalytic biomolecule using microfluidic techniques.
    Type: Application
    Filed: October 8, 2019
    Publication date: November 18, 2021
    Inventors: Laurynas Karpus, Ignas Mazelis, Irmantas Rokaitis, Vykintas Jauniskis, Rolandas Meskys
  • Publication number: 20200270295
    Abstract: Disclosed are W-position modified cytidine nucleotides of formula (I). Provided herein are methods of chemical synthesis of AP-modified cytidine nucleoside triphosphates and their applications as well as uses of the cytidine analogues for the synthesis of modified nucleic acids. The nucleic acid molecule includes DNA, RNA or a combination of DNA/RNA. One of many applications of modified cytidine nucleotides described herein is enzyme selection, when an enzyme of interest bears an activity of an esterase, amidase, oxidoreductase, lyase, ligase or other enzymatic activity, formula (I) wherein the substituants are as defined in the appended claims.
    Type: Application
    Filed: September 12, 2018
    Publication date: August 27, 2020
    Inventors: Rolandas MESKYS, Jevgenija JAKUBOVSKA, Daiva TAURAITE
  • Patent number: 8580547
    Abstract: The invention relates to novel PQQ-dependent soluble glucose dehydrogenases (sPQQGDH) which have an increased substrate specificity compared with the wild type, and also to methods for production and identification thereof.
    Type: Grant
    Filed: June 17, 2009
    Date of Patent: November 12, 2013
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Walter Weichel, Volker Möhrle, Markus Schindler, Rainhard Koch, Rolandas Meskys
  • Publication number: 20110236920
    Abstract: The invention relates to novel PQQ-dependent soluble glucose dehydrogenases (sPQQGDH) which have an increased substrate specificity compared with the wild type, and also to methods for production and identification thereof.
    Type: Application
    Filed: June 17, 2009
    Publication date: September 29, 2011
    Inventors: Walter Weichel, Volker Möhrle, Markus Schindler, Rainhard Koch, Rolandas Meskys
  • Publication number: 20090087874
    Abstract: The invention relates to novel PQQ-dependent soluble glucose dehydrogenases (sPQQGDH) from Acinetobacter and to a process for their preparation by overexpression in suitable microbial expression systems.
    Type: Application
    Filed: October 6, 2008
    Publication date: April 2, 2009
    Applicant: BAYER TECHNOLOGY SERVICES GMBH
    Inventors: Ruth MEISSNER, Walter WEICHEL, Rainhard KOCH, Irina BACHMATOVA, Liucija MARCINKEVICIENE, Rita MESKIENE, Rasa SEMENAITE, Vida CASAITE, Rolandas MESKYS
  • Patent number: 7432096
    Abstract: The invention relates to novel PQQ-dependent soluble glucose dehydrogenases (sPQQGDH) from Acinetobacter and to a process for their preparation by overexpression in suitable microbial expression systems.
    Type: Grant
    Filed: April 27, 2004
    Date of Patent: October 7, 2008
    Assignee: Bayer Technology Services GmbH
    Inventors: Ruth Meissner, Walter Weichel, Rainhard Koch, Irina Bachmatova, Liucija Marcinkeviciene, Rita Meskiene, Rasa Semenaite, Vida Casaite, Rolandas Meskys
  • Publication number: 20060263838
    Abstract: The invention relates to novel PQQ-dependent soluble glucose dehydrogenases (sPQQGDH) from Acinetobacter and to a process for their preparation by overexpression in suitable microbial expression systems.
    Type: Application
    Filed: April 27, 2004
    Publication date: November 23, 2006
    Applicant: Bayer Technology Services GmbH
    Inventors: Ruth Meissner, Walter Weichel, Rainhard Koch, Irina Bachmatova, Liucija Marcinkeviciene, Rita Meskiene, Rasa Semenaite, Vida Casaite, Rolandas Meskys